Research Article

Antibacterial and Antioxidant Activity Evaluation of Bis-Substituted İsovanillin Derivatives

Volume: 10 Number: 2 May 31, 2023
EN

Antibacterial and Antioxidant Activity Evaluation of Bis-Substituted İsovanillin Derivatives

Abstract

Herein, a series of twelve bis-hydrazone substituted isovanilline derivatives 3(a-l), were freshly re-synthesized by the reaction of bis-aldehydes with substituted hydrazide derivatives since these compounds previously showed potent aldose reductase inhibition properties. The obtained compounds were tested for their potential antibacterial and antioxidant activities. In the present study, four different bacterial strains were used, including Gram-positive (Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212) and Gram-negative (Pseudomonas aeruginosa ATCC 10231, Escherichia coli ATCC 25912). On the other hand, the antioxidant capacities of freshly re-synthesized bis-hydrazone substituted isovanilline derivatives were determined by using several antioxidant methods, including DPPH free radical scanvenging, TEAC cupric reducing (CUPRAC) and metal chelating activity methods. Several lead molecules were discovered as a potential bacterial inhibitors against S. aureus and E. coli bacterial strains. More specifically, compounds 3g (R=-H) and 3j (R= -4Cl) showed great inhibition properties against E. coli bacterial strains by having MIC values of 1.56 and 6.25 µg/mL, respectively. Moreover, none of the compounds showed potent antioxidant activity against tested methods with respect to compared standards.

Keywords

Supporting Institution

Istanbul Technical University Grants Commission

Project Number

33467

Thanks

This work was partially funded by the Istanbul Technical University Grants Commission for a research grant (Project Grant No: 33467).

References

  1. 1. Doron S, Gorbach SL. Bacterial Infections: Overview. In: International Encyclopedia of Public Health [Internet]. Elsevier; 2008. p. 273–82.
  2. 2. Nikaido H. Multidrug Resistance in Bacteria. Annu Rev Biochem [Internet]. 2009 Jun 1;78(1):119–46.
  3. 3. Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet [Internet]. 2016 Jan 9;387(10014):176–87.
  4. 4. Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature [Internet]. 2016 Jan 20;529(7586):336–43.
  5. 5. Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov [Internet]. 2021 Mar 28;20(3):200–16.
  6. 6. Yang L, Feng F, Gao Y. Chemical constituents from herb of Solanum lyratum. China J Chinese Mater medica [Internet]. 2009;34(14):1805–8.
  7. 7. Xu J, Tan N, Zeng G, Han H, Huang H, Ji C, et al. Studies on chemical constituents in fruit of Alpinia oxyphylla. China J Chinese Mater medica [Internet]. 2009;34(8):990–3.
  8. 8. Chen W, Tang S, Qin N, Zhai H, Duan H. Antioxidant constituents from Smilax riparia. China J Chinese Mater medica [Internet]. 2012;37(6):806–10.

Details

Primary Language

English

Subjects

Biochemistry and Cell Biology (Other)

Journal Section

Research Article

Publication Date

May 31, 2023

Submission Date

October 29, 2022

Acceptance Date

February 16, 2023

Published in Issue

Year 2023 Volume: 10 Number: 2

APA
Tekin, Z., Tekeli, Y., Küçükbay, Z., Lolak, N., Yapar, G., & Akocak, S. (2023). Antibacterial and Antioxidant Activity Evaluation of Bis-Substituted İsovanillin Derivatives. Journal of the Turkish Chemical Society Section A: Chemistry, 10(2), 435-442. https://doi.org/10.18596/jotcsa.1196335
AMA
1.Tekin Z, Tekeli Y, Küçükbay Z, Lolak N, Yapar G, Akocak S. Antibacterial and Antioxidant Activity Evaluation of Bis-Substituted İsovanillin Derivatives. JOTCSA. 2023;10(2):435-442. doi:10.18596/jotcsa.1196335
Chicago
Tekin, Zehra, Yener Tekeli, Zehra Küçükbay, Nebih Lolak, Gönül Yapar, and Süleyman Akocak. 2023. “Antibacterial and Antioxidant Activity Evaluation of Bis-Substituted İsovanillin Derivatives”. Journal of the Turkish Chemical Society Section A: Chemistry 10 (2): 435-42. https://doi.org/10.18596/jotcsa.1196335.
EndNote
Tekin Z, Tekeli Y, Küçükbay Z, Lolak N, Yapar G, Akocak S (May 1, 2023) Antibacterial and Antioxidant Activity Evaluation of Bis-Substituted İsovanillin Derivatives. Journal of the Turkish Chemical Society Section A: Chemistry 10 2 435–442.
IEEE
[1]Z. Tekin, Y. Tekeli, Z. Küçükbay, N. Lolak, G. Yapar, and S. Akocak, “Antibacterial and Antioxidant Activity Evaluation of Bis-Substituted İsovanillin Derivatives”, JOTCSA, vol. 10, no. 2, pp. 435–442, May 2023, doi: 10.18596/jotcsa.1196335.
ISNAD
Tekin, Zehra - Tekeli, Yener - Küçükbay, Zehra - Lolak, Nebih - Yapar, Gönül - Akocak, Süleyman. “Antibacterial and Antioxidant Activity Evaluation of Bis-Substituted İsovanillin Derivatives”. Journal of the Turkish Chemical Society Section A: Chemistry 10/2 (May 1, 2023): 435-442. https://doi.org/10.18596/jotcsa.1196335.
JAMA
1.Tekin Z, Tekeli Y, Küçükbay Z, Lolak N, Yapar G, Akocak S. Antibacterial and Antioxidant Activity Evaluation of Bis-Substituted İsovanillin Derivatives. JOTCSA. 2023;10:435–442.
MLA
Tekin, Zehra, et al. “Antibacterial and Antioxidant Activity Evaluation of Bis-Substituted İsovanillin Derivatives”. Journal of the Turkish Chemical Society Section A: Chemistry, vol. 10, no. 2, May 2023, pp. 435-42, doi:10.18596/jotcsa.1196335.
Vancouver
1.Zehra Tekin, Yener Tekeli, Zehra Küçükbay, Nebih Lolak, Gönül Yapar, Süleyman Akocak. Antibacterial and Antioxidant Activity Evaluation of Bis-Substituted İsovanillin Derivatives. JOTCSA. 2023 May 1;10(2):435-42. doi:10.18596/jotcsa.1196335

Cited By